<p><strong>Adults</strong>: The most common adverse reactions (&ge;5%) in patients treated with Ertapenem, including those who were switched to therapy with an oral antimicrobial, were diarrhea, nausea, headache and infused vein complication. In the prophylaxis indication, the overall adverse experience profile was generally comparable to that observed for ertapenem in other clinical trials.<br />
<br />
<strong>Pediatrics</strong>: Adverse reactions in this population were comparable to adults. The most common adverse reactions (&ge;5%) in pediatric patients treated with Ertapenem, including those who were switched to therapy with an oral antimicrobial, were diarrhea, vomiting and infusion site pain.</p>